Search research articles
Contact Us
Filters
Showing results (191-200 of 228) with videos related to
Page
of 23
Sort By:
Analytical Chemistry
|
December 6, 2019
Endogenous Cys-Assisted GSH@AgNCs-rGO Nanoprobe for Real-Time Monitoring of Dynamic Change in GSH Levels Regulated by Natural Drug
Yan Qin, Jialong Fan, Wei Yang, et al.
Leukemia & Lymphoma
|
February 3, 2018
Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop
Daryl Tan, Jae Hoon Lee, Wenming Chen, et al.
Cancer Medicine
|
May 28, 2026
Clinical Characteristics, Treatment Patterns, and Prognosis of Central Nervous System Involvement in Multiple Myeloma: A Multicenter Retrospective Study From China
Wenjing Li, Weiwei Tian, Jie Ma, et al.
Journal of Medicinal Chemistry
|
March 4, 2015
Design and synthesis of orally bioavailable aminopyrrolidinone histone deacetylase 6 inhibitors
Xianfeng Lin, Wenming Chen, Zongxing Qiu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 8, 2025
Perspectives on Anti-BCMA Bispecific Antibodies use in Multiple Myeloma-Experience from Asian Countries
Cinnie Soekojo, Shimin Jasmine Chung, Ming-Tao Tsai, et al.
Blood Advances
|
October 29, 2025
Long term Follow-up of Zevor-cel in Patients with Relapsed/Refractory Multiple Myeloma
Chengcheng Fu, Wenming Chen, Zhen Cai, et al.
Clinical Hematology International
|
April 24, 2025
Consensus Guidelines and Recommendations for The CD38 Monoclonal Antibody-based Quadruplet Therapy and Management in Clinical Practice for Newly Diagnosed Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group
Wenming Chen, Zhen Cai, James Cs Chim, et al.
Cancer Medicine
|
April 30, 2024
Assessment of prolonged proteasome inhibition through ixazomib-based oral regimen on newly diagnosed and first-relapsed multiple myeloma: A real-world Chinese cohort study
Aijun Liu, Hong Yu, Rui Hou, et al.
Annals of Hematology
|
July 29, 2024
Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort study
Jingjing Deng, Xiaoqi Qin, Guangyu Ma, et al.
International Journal of Hematology
|
January 3, 2021
A study of carfilzomib and dexamethasone in patients with relapsed and refractory multiple myeloma in China
Juan Du, Baijun Fang, Jian Li, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 228) with videos related to
Sort By:
Page
of 23
Analytical Chemistry
|
December 6, 2019
Endogenous Cys-Assisted GSH@AgNCs-rGO Nanoprobe for Real-Time Monitoring of Dynamic Change in GSH Levels Regulated by Natural Drug
Yan Qin, Jialong Fan, Wei Yang, et al.
Leukemia & Lymphoma
|
February 3, 2018
Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop
Daryl Tan, Jae Hoon Lee, Wenming Chen, et al.
Cancer Medicine
|
May 28, 2026
Clinical Characteristics, Treatment Patterns, and Prognosis of Central Nervous System Involvement in Multiple Myeloma: A Multicenter Retrospective Study From China
Wenjing Li, Weiwei Tian, Jie Ma, et al.
Journal of Medicinal Chemistry
|
March 4, 2015
Design and synthesis of orally bioavailable aminopyrrolidinone histone deacetylase 6 inhibitors
Xianfeng Lin, Wenming Chen, Zongxing Qiu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 8, 2025
Perspectives on Anti-BCMA Bispecific Antibodies use in Multiple Myeloma-Experience from Asian Countries
Cinnie Soekojo, Shimin Jasmine Chung, Ming-Tao Tsai, et al.
Blood Advances
|
October 29, 2025
Long term Follow-up of Zevor-cel in Patients with Relapsed/Refractory Multiple Myeloma
Chengcheng Fu, Wenming Chen, Zhen Cai, et al.
Clinical Hematology International
|
April 24, 2025
Consensus Guidelines and Recommendations for The CD38 Monoclonal Antibody-based Quadruplet Therapy and Management in Clinical Practice for Newly Diagnosed Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group
Wenming Chen, Zhen Cai, James Cs Chim, et al.
Cancer Medicine
|
April 30, 2024
Assessment of prolonged proteasome inhibition through ixazomib-based oral regimen on newly diagnosed and first-relapsed multiple myeloma: A real-world Chinese cohort study
Aijun Liu, Hong Yu, Rui Hou, et al.
Annals of Hematology
|
July 29, 2024
Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort study
Jingjing Deng, Xiaoqi Qin, Guangyu Ma, et al.
International Journal of Hematology
|
January 3, 2021
A study of carfilzomib and dexamethasone in patients with relapsed and refractory multiple myeloma in China
Juan Du, Baijun Fang, Jian Li, et al.
Page
of 23